KRAS and cervical squamous intraepithelial neoplasia: This cluster had the fewest TP53 mutations (6%), a result consistent with a role for p53 in preventing multiple types of CIN, but the largest fractions of KRAS mutations (83%) and SBS18 activity (97%).